Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma

Am J Physiol. 1995 May;268(5 Pt 1):E996-1006. doi: 10.1152/ajpendo.1995.268.5.E996.

Abstract

Rats implanted with Yoshida ascites hepatoma (YAH) show a rapid and selective loss of muscle protein due mainly to a marked increase (63-95%) in the rate of protein degradation (compared with rates in muscles of pair-fed controls). To define which proteolytic pathways contribute to this increase, epitrochlearis muscles from YAH-bearing and control rats were incubated under conditions that modify different proteolytic systems. Overall proteolysis in either group of rats was not affected by removal of Ca2+ or by blocking the Ca(2+)-dependent proteolytic system. Inhibition of lysosomal function with methylamine reduced proteolysis (-12%) in muscles from YAH-bearing rats, but not in muscles of pair-fed rats. When ATP production was also inhibited, the remaining accelerated proteolysis in muscles of tumor-bearing rats fell to control levels. Muscles of YAH-bearing rats showed increased levels of ubiquitin-conjugated proteins and a 27-kDa proteasome subunit in Western blot analysis. Levels of mRNA encoding components of proteolytic systems were quantitated using Northern hybridization analysis. Although their total RNA content decreased 20-38%, pale muscles of YAH-bearing rats showed increased levels of ubiquitin mRNA (590-880%) and mRNA for multiple subunits of the proteasome (100-215%). Liver, kidney, heart, and brain showed no weight loss and no change in these mRNA species. Muscles of YAH-bearing rats also showed small increases (30-40%) in mRNA for cathepsins B and D, but not for calpain I or heat shock protein 70. Our findings suggest that accelerated muscle proteolysis and muscle wasting in tumor-bearing rats result primarily from activation of the ATP-dependent pathway involving ubiquitin and the proteasome.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adenosine Triphosphate / metabolism*
  • Animals
  • Biopolymers / genetics
  • Blotting, Western
  • Cachexia / metabolism
  • Carcinoma, Hepatocellular / metabolism*
  • Carcinoma, Hepatocellular / pathology
  • Cysteine Endopeptidases / classification
  • Cysteine Endopeptidases / genetics
  • Cysteine Endopeptidases / metabolism*
  • Female
  • Liver Neoplasms / metabolism*
  • Liver Neoplasms / pathology
  • Multienzyme Complexes / classification
  • Multienzyme Complexes / genetics
  • Multienzyme Complexes / metabolism*
  • Muscle, Skeletal / metabolism*
  • Muscle, Skeletal / pathology
  • Organ Size
  • Polyubiquitin
  • Protease Inhibitors / pharmacology
  • Proteasome Endopeptidase Complex
  • RNA / metabolism
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Ubiquitins / classification
  • Ubiquitins / genetics
  • Ubiquitins / metabolism*

Substances

  • Biopolymers
  • Multienzyme Complexes
  • Protease Inhibitors
  • RNA, Messenger
  • Ubiquitins
  • Polyubiquitin
  • RNA
  • Adenosine Triphosphate
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex